Variables | MSA | PD | X2value on 1 df | Sensitivity (%) | Specificity (%) | PPV | NPV | Youden index | |
---|---|---|---|---|---|---|---|---|---|
Sociodemographic: | |||||||||
Sex | (M) | 20 | 64 | 0.22 | 52.6 | 36.0 | 23.8 | 66.7 | −11.4 |
(F) | 18 | 36 | |||||||
Age onset⩽55 y | (Y) | 16 | 20 | 0.008 | 42.1 | 80.0 | 44.4 | 78.4 | 22.1 |
(N) | 22 | 80 | |||||||
Initial features: | |||||||||
Symmetric onset | (Y) | 9 | 28 | 0.99 | 28.1 | 71.7 | 24.3 | 75.5 | −0.2 |
(N) | 23 | 71 | |||||||
Initial HY>2 | (Y) | 13 | 21 | 0.002 | 54.2 | 78.1 | 38.2 | 87.2 | 32.3 |
(N) | 11 | 75 | |||||||
Initial rigidity | (Y) | 21 | 30 | 0.005 | 56.8 | 69.7 | 41.2 | 81.2 | 26.5 |
(N) | 16 | 69 | |||||||
Initial poor levodopa response | (Y) | 18 | 22 | 0.0001 | 58.1 | 76.8 | 45.0 | 84.9 | 34.9 |
(N) | 13 | 73 | |||||||
Clinical features2-150: | |||||||||
Tremor | (Y) | 23 | 76 | 0.07 | 60.5 | 24.0 | 23.2 | 61.5 | −15.5 |
(N) | 15 | 24 | |||||||
Rigidity | (Y) | 37 | 96 | 0.7 | 97.4 | 4.0 | 27.8 | 80.0 | 1.4 |
(N) | 1 | 4 | |||||||
Bradykinesia | (Y) | 36 | 90 | 0.16 | 97.3 | 10.0 | 28.6 | 90.9 | 7.3 |
(N) | 1 | 10 | |||||||
Autonomic | (Y) | 32 | 26 | 0.0001 | 84.2 | 73.7 | 55.2 | 92.4 | 57.9 |
(N) | 6 | 73 | |||||||
Cerebellar | (Y) | 12 | 1 | 0.0001 | 32.4 | 99.0 | 92.3 | 79.7 | 31.4 |
(N) | 25 | 98 | |||||||
Pyramidal | (Y) | 18 | 7 | 0.0001 | 50.0 | 92.9 | 72.0 | 83.6 | 42.9 |
(N) | 18 | 92 | |||||||
Speech and/or bulbar | (Y) | 33 | 21 | 0.0001 | 86.8 | 78.8 | 61.1 | 94.0 | 65.6 |
(N) | 5 | 78 | |||||||
Dementia absent | (Y) | 29 | 44 | 0.0001 | 82.9 | 54.6 | 39.7 | 89.8 | 37.5 |
(N) | 6 | 53 | |||||||
Early dementia absent | (Y) | 29 | 78 | 0.01 | 100.0 | 17.9 | 27.1 | 100.0 | 17.9 |
(N) | 0 | 17 | |||||||
Asymmetric disease | (Y) | 13 | 54 | 0.033 | 34.2 | 45.5 | 19.4 | 64.3 | −20.3 |
(N) | 25 | 45 | |||||||
Drug side effects: | |||||||||
Toxic confusion absent | (Y) | 27 | 27 | 0.0001 | 84.4 | 71.9 | 50.0 | 93.2 | 56.3 |
(N) | 5 | 69 | |||||||
Early toxic confusion absent | (Y) | 27 | 80 | 0.04 | 100.0 | 14.0 | 25.2 | 100.0 | 14.0 |
(N) | 0 | 13 | |||||||
Fluctuations | (Y) | 15 | 58 | 0.18 | 46.9 | 39.6 | 20.5 | 69.1 | −13.5 |
(N) | 17 | 38 | |||||||
Early fluctuations | (Y) | 14 | 19 | 0.006 | 45.2 | 80.0 | 42.4 | 81.7 | 25.2 |
(N) | 17 | 76 | |||||||
Dyskinesia | (Y) | 15 | 59 | 0.14 | 45.5 | 39.8 | 20.3 | 68.4 | −14.7 |
(N) | 18 | 39 | |||||||
Early dyskinesias | (Y) | 8 | 18 | 0.43 | 25.0 | 81.4 | 30.8 | 76.7 | 6.4 |
(N) | 24 | 79 | |||||||
Other features: | |||||||||
Other signs | (Y) | 30 | 12 | 0.0001 | 78.9 | 88.0 | 71.4 | 91.7 | 66.9 |
(N) | 8 | 88 | |||||||
Other causes | (Y) | 3 | 20 | 0.09 | 7.9 | 80.0 | 13.0 | 69.6 | −12.1 |
(N) | 35 | 80 | |||||||
Depression | (Y) | 14 | 56 | 0.24 | 51.9 | 35.6 | 20.0 | 70.5 | −12.5 |
(N) | 13 | 31 | |||||||
Falls | (Y) | 31 | 54 | 0.001 | 86.1 | 44.3 | 36.5 | 89.6 | 30.4 |
(N) | 5 | 43 | |||||||
Family history | (Y) | 2 | 4 | 0.65 | 5.9 | 96.0 | 33.3 | 75.0 | 1.9 |
(N) | 32 | 96 |
PPV=positive predictive value; NPV=negative predictive value.
↵2-150 Recorded at any time up to death.
Youden index = sensitivity plus specificity minus 100. Values can vary from between 100 to−100, a larger value indicating a more useful feature.